Medicine and Dentistry
Rectum Cancer
59%
Chemoradiotherapy
54%
Cell-Free DNA
53%
Anal Cancer
52%
Colorectal Cancer
41%
Squamous Cell Carcinoma
40%
Radiation Therapy
36%
Metastatic Colorectal Cancer
34%
Anus
31%
Overall Survival
25%
Neoplasm
23%
Circulating Tumor DNA
23%
Recurrent Disease
20%
Systematic Review
19%
Metastatic Carcinoma
18%
Biological Marker
17%
Disease
17%
Bladder
15%
Pelvis
13%
Patient-Reported Outcome
13%
Brain Metastasis
11%
Re-Irradiation
11%
Meta-Analysis
11%
Malignant Neoplasm
11%
Progression Free Survival
10%
Acute Toxicity
10%
Liver Metastasis
9%
Surgery
9%
Hazard Ratio
9%
Femoral Head
8%
Wart Virus
8%
Capecitabine
8%
Lung Metastasis
8%
Carcinoembryonic Antigen
8%
Adverse Event
8%
DNA
7%
Epidermal Growth Factor Receptor
7%
Positron Emission Tomography-Computed Tomography
7%
Anal Canal
7%
Cell Free DNA
7%
Colon Cancer
7%
Rectal Administration
7%
FOLFIRI
7%
Watchful Waiting
7%
Total Mesorectal Excision
7%
Microsurgery
7%
Proton Therapy
7%
Translational Research
6%
Intensity Modulated Radiation Therapy
6%
Irinotecan
6%
Pharmacology, Toxicology and Pharmaceutical Science
Metastatic Colorectal Cancer
100%
Neoplasm
50%
Chemoradiation Therapy
47%
Colorectal Cancer
44%
Chemotherapy
41%
Circulating Tumor DNA
39%
Overall Survival
34%
Rectum Cancer
31%
Anus Cancer
31%
Squamous Cell Carcinoma
31%
Biological Marker
25%
Progression Free Survival
25%
Irinotecan
24%
Malignant Neoplasm
23%
Epidermal Growth Factor Receptor
21%
Recurrent Disease
20%
Disease
18%
Capecitabine
16%
Oxaliplatin
14%
Cetuximab
14%
Liver Metastasis
14%
Acute Toxicity
13%
Carcinoembryonic Antigen
13%
Colon Cancer
12%
Non Small Cell Lung Cancer
11%
Phase II Trials
9%
Solid Malignant Neoplasm
9%
Vasculotropin A
8%
Bevacizumab
8%
Human Papillomavirus
8%
DNA
7%
Adverse Event
6%
Lung Metastasis
6%
Primary Tumor
5%
Comorbidity
5%
Vasculotropin
5%
Tumor Marker
5%
Tissue Inhibitor of Metalloproteinase
5%
Biochemistry, Genetics and Molecular Biology
Overall Survival
34%
KRAS
31%
Epidermal Growth Factor Receptor
23%
Circulating Tumor DNA
21%
Droplet Digital Polymerase Chain Reaction
19%
Progression Free Survival
16%
Single-Nucleotide Polymorphism
15%
Vascular Endothelial Growth Factor A
14%
Cetuximab
12%
Colon
12%
Multivariate Analysis
12%
Genotyping
11%
Real-Time Polymerase Chain Reaction
11%
Capecitabine
10%
Vascular Endothelial Growth Factor
10%
Allele
9%
Dynamics
9%
Haplotype
9%
Anus
7%
Gene Polymorphism
7%
Epidermal Growth Factor
6%
Lymphocyte
6%
Disease Free Survival
6%
Plasma Cell
5%
Medline
5%
DNA Analysis
5%
Embase
5%
Biomarker Study
5%
Tumor Volume
5%
Germ Cell
5%
Germline
5%
